High-intensity focused ultrasound (HIFU) for the treatment of female urinary incontinence: A retrospective analysis
- PMID: 39465710
- PMCID: PMC11460924
- DOI: 10.1097/MD.0000000000039940
High-intensity focused ultrasound (HIFU) for the treatment of female urinary incontinence: A retrospective analysis
Abstract
This study aims to demonstrate the effectiveness of high-intensity focused ultrasound, a noninvasive treatment, for managing urinary incontinence (UI) in women. This is a single-center, retrospective study involving 28 women. Patients, aged between 32 and 65, were included. Patients with insulin-dependent diabetes, neurological disease, active urinary tract infection, undiagnosed vaginal bleeding, who had incontinence surgery, and receiving estrogen therapy were excluded from the study. Incontinence severity was evaluated with the International Incontinence Consultation Questionnaire Short Form (ICIQ-SF). Patients were evaluated before treatment and 6 months after treatment using the ICIQ-SF and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Assessment short form. In the analysis of numerical variables independent or paired t test or linear mixed effects models were used. Least square means were used in post hoc comparisons. Mean age of the patients was 45.50 ± 7.59 years. There were 18 (64%) stress urinary incontinence (SUI) and 10 (36%) mixed urinary incontinence (MUI). Six months after treatment, mean ICIQ-SF and Pelvic Organ Prolapse/Urinary Incontinence Short Form Questionnaire scores showed a significant positive change. After the procedure, UI completely disappeared in 43% of the patients. The rate of severe UI decreased from 39% to 8%, and very severe UI decreased from 8% to 0%. Incontinence severity was significantly different in the MUI and SUI groups before and after the procedure. After the procedure, UI completely disappeared in 67% of the patients in the SUI group, while it remained at a mild level in 33%. The decrease in ICIQ-SF score in the SUI group was significantly higher than that in the MUI group. There were no severe adverse events, in 4 patients there was mild vaginal discharge which resolved in 1 week. This study showed that high-intensity focused ultrasound treatment, can be effective and safe even in a single session. Selection and recall biases are potential biases in retrospective studies. Lacking a control group is another limitation. Although advances in technology are very important for medical treatments, their effectiveness and safety need to be proven. Future research in this area with a larger sample size and a prospective design will offer further evidence supporting effectiveness of this treatment model.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures


Similar articles
-
What happens to urinary incontinence after pelvic organ prolapse surgery?Int Urogynecol J. 2019 Jul;30(7):1147-1152. doi: 10.1007/s00192-018-3677-4. Epub 2018 Jun 5. Int Urogynecol J. 2019. PMID: 29869693
-
Efficacy of the use of fractional CO2RE intima laser treatment in stress and mixed urinary incontinence.Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:95-100. doi: 10.1016/j.ejogrb.2019.10.048. Epub 2019 Nov 12. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31778906
-
ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence.Neurourol Urodyn. 2015 Nov;34(8):747-51. doi: 10.1002/nau.22657. Epub 2014 Aug 22. Neurourol Urodyn. 2015. PMID: 25154378 Clinical Trial.
-
Safety and efficacy of vaginal laser therapy for stress urinary incontinence: a meta-analysis.Ann Palliat Med. 2021 Mar;10(3):2736-2746. doi: 10.21037/apm-20-1440. Epub 2021 Jan 26. Ann Palliat Med. 2021. PMID: 33549008
-
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women.Cochrane Database Syst Rev. 2018 Oct 4;10(10):CD005654. doi: 10.1002/14651858.CD005654.pub4. Cochrane Database Syst Rev. 2018. PMID: 30288727 Free PMC article.
References
-
- Almousaa S, van Loon AB. The prevalence of urinary incontinence in nulliparous adolescent and middle-aged women and the associated risk factors: a systematic review. Maturitas. 2018;107:78–83. - PubMed
-
- Haylen BT, Ridder D, Freeman RM, et al. . An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20. - PubMed
-
- Cervigni M, Gambacciani M. Female urinary stress incontinence. Climacteric. 2015;18(Suppl 1):30–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical